USE OF CITRONELLOL IN PREPARING PREPARATION FOR PROMOTING EXPRESSION OF VIRULENCE GENE TOXA OF PSEUDOMONAS AERUGINOSA
20230010612 · 2023-01-12
Assignee
Inventors
- Wenru LI (Guangzhou, CN)
- Xiaobao Xie (Guangzhou, CN)
- Taohua ZENG (Guangzhou, CN)
- Zhiqing ZHANG (Guangzhou, CN)
- Jingxia LIU (Guangzhou, CN)
- Qingshan Shi (Guangzhou, CN)
Cpc classification
Y02A50/30
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
International classification
Abstract
A use of citronellol in preparing a preparation for promoting an expression of a virulence gene toxA of Pseudomonas aeruginosa is disclosed. It was found that citronellol slightly inhibits the growth of a Pseudomonas aeruginosa PAO1 strain and can promote the transcription of the toxA of Pseudomonas aeruginosa, which can increase the yield of an exotoxin A, namely, an encoded product of toxA. Therefore, citronellol is applicable to the preparation of a preparation for promoting the expression of the virulence gene toxA of Pseudomonas aeruginosa.
Claims
1. Use of citronellol in preparing a preparation for promoting an expression of a virulence gene toxA of Pseudomonas aeruginosa.
2. The use according to claim 1, wherein the Pseudomonas aeruginosa is Pseudomonas aeruginosa PAO1.
3. The use according to claim 1, wherein the use of the citronellol in preparing the preparation for promoting production of an exotoxin A in the Pseudomonas aeruginosa.
4. The use according to claim 1, wherein the citronellol is β-citronellol.
5. The use according to claim 1, wherein a concentration of the citronellol in a Pseudomonas aeruginosa culture solution is 0.313-2.5 μL/mL.
6. The use according to claim 5, wherein the concentration of the citronellol in the Pseudomonas aeruginosa culture solution is 1.25 μL/mL.
7. The use according to claim 2, wherein the use of the citronellol in preparing the preparation for promoting production of an exotoxin A in the Pseudomonas aeruginosa.
8. The use according to claim 2, wherein the citronellol is β-citronellol.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0014]
[0015]
DETAILED DESCRIPTION
[0016] The embodiments below are intended to further explain the present invention, instead of limiting the present invention.
Embodiment 1
[0017] Preparation of PAO1[(Pseudomonas aeruginosa) PAO1] bacterial suspension: a culture solution of Pseudomonas aeruginosa PAO1 in an exponential growth phase was sampled, centrifuged, washed once with a PBS buffer, resuspended in PBS, and diluted to 10.sup.8 CFU/mL to obtain the PAO1 bacterial suspension.
[0018] 1. Experiment on Effects of Citronellol on the Growth of Pseudomonas aeruginosa PAO1
[0019] An LB culture medium and citronellol (ii-citronellol) were added to test tubes respectively, and the PAO1 bacterial suspension in the exponential growth phase was inoculated to reach a total volume of 10 mL respectively. The bacterial concentration of PAO1 was each 10.sup.6 CFU/mL, and the concentration of citronellol was 0 (control), 0.313 μL/mL, 0.625 μL/mL, 1.25 μL/mL, and 2.5 μL/mL, respectively. Samples from several test groups were added to a honeycomb culture plate dedicated to an automatic growth curve analyzer (Bioscreen C), and 350 μL of culture solution was added to each well, with three parallel for each test group. The honeycomb culture plate was placed in the automatic growth curve analyzer, and cultured over shaking at 37° C. for 3 days, and OD.sub.600 was measured every hour. Taking OD.sub.600 as the ordinate and a culture time as the abscissa, the growth curve of PAO1 under the action of citronellol was drawn to study the effect of the citronellol on the growth of PAO1. The results were shown as in
[0020] 2. Experiment on Effects of Citronellol on the Expression of Key Genes in a Quorum-Sensing System of Pseudomonas aeruginosa and Virulence Genes Regulated Thereby
[0021] The PAO1 bacterial suspension in a logarithmic growth phase was added to 50 mL of sterile LB liquid culture medium to reach a final concentration of 10.sup.6 CFU/mL for the bacterial solution. Citronellol (1$-citronellol) was added to reach the final concentrations of 0 (three biological replicates in the control group were named A1, A2, and A3, respectively) and 1.25 μL/mL (three biological replicates in the test groups were named B1, B2, B3). Each group was cultured at 37° C. and 180 rpm for 5 h, and centrifuged to collect bacteria, which were then quick-frozen at −80° C. for later use.
[0022] Total RNAs were extracted from the bacteria by a Trizol (Thermo Fisher Scientific) kit. After extraction, the purity of the RNAs were detected with an ultra-micro spectrophotometer (Implen, Munich, Germany). An A260/A280 value of each RNA sample should be between 1.8 and 2.0. Reverse transcription and real-time fluorescent quantitative PCR amplification were carried out by using a PrimeScript RT Master Mix kit (Takara, Dalian, China) and an ETC 811 PCR instrument (Eastwin Life Sciences, Inc.). A q-PCR reaction system included Takara SYBR Premix Ex TaqII (Tli RNaseH Plus) (Code No. RR820A), and PCR procedures included: pre-denaturation at 95° C. for 30 s; and denaturation at 95° C. for 5 s and annealing at 60° C. for 34 s, 40 cycles. Based on 10 gene sequences published on the website of GenBank, primers for q-PCR were designed by using software Primer Premier 5.0, and at the same time, a 168 rRNA gene was used as an internal reference gene. The primer sequence parameters are shown in Table 1.
TABLE-US-00001 TABLE 1 Genes and printer sequences thereof used in real-time fluorescent quantitative PCR Gene name Locus Gene description Primer sequences (5′.fwdarw.3′) 16S rRNA PA5369.5 16S ribosomal RNA GCGCAACCCTTGTCCTTAGTT (F) TGTCACCGGCAGTCTCCTTAG (R) lasI PA1432 Acyl-homoserine-lactone synthase TGCGTGCTCAAGTGTTCAAGG (F) CGGCTGAGTTCCCAGATGTGC (R) lasR PA1430 Transcriptional regulator LasR GACCAGTTGGGAGATATCGGTTA (F) TCCGCCGAATATTTCCCATA (R) rhlI PA3476 Acyl-homoserine-lactone synthase AAACCCGCTACATCGTCGC (F) TCTCGCCCTTGACCTTCTGC (R) rhlR PA3477 Transcriptional regulator RhlR ATCGCCATCATCCTGAGCATT (F) TCGGAGGACATACCAGCACAC (R) pqsA PA0996 Anthranilate-CoA ligase GCAATACACCTCGGGTTCCA (F) TCCGCTGAACCAGGGAAAGA (R) pqsR PA1003 Transcriptional regulator TCGTTCTGCGATACGGTGAG (F) GCACTGGTTGAAGCGGGAG (R) lasA PA1871 Protease LasA GCCGCTGAATGACGACCTGT (F) TCAGGGTCAGCAACACTT (R) lasB PA3724 Elastase LasB AAGGCCTTGCGGGTATCC (F) CGTGTACAACCGTGCGTTCT (R) phzM PA4209 Phenazine-specific GAATGGAAGTCCCGTTGC (F) methyltransferase GCCCTCGACATCCCTCA (R) chiC PA2300 Chitinase CTGGGAGTTCCGCAAGCGTTAC (F) ATCGGTGGCGGTGACGAAATAG (R) toxA PA1148 Exotoxin A CCCGGCGAAGCATGAC (R) GGGAAATGCAGGCGATGA (R) pslB PA2232 Biofilm formation protein PslB CAACGAATCCACCTTCATCC (F) ACTCGCCGCTCTGTACCTC (R)
[0023] Experimental Results:
[0024] The results on the growth curves of Pseudomonas aeruginosa PAO1 under the action of citronellol at different concentrations are shown in
[0025]
[0026] In summary, the experimental results demonstrate that the citronellol slightly inhibits the growth of Pseudomonas aeruginosa PAO1 strains (